Medical imaging "of the third kind"
Since the early 20th century Guerbet has been contributing to major advances in medical imaging so that patients worldwide receive better care.
Imaging has progressed from evidencing anatomical shapes to describing the functional performance of the main organs.
The future use of cellular and molecular imaging heralds the birth of imaging "of the third kind" which will be able to characterize anomalies and measure the effectiveness of a patient's treatment.
Guerbet is banking on innovation in MRI which is currently the most promising solution to facilitate the detection of biological anomalies.
In matters of cellular and molecular imaging, MRI has a number of advantages:
- development of new drugs and therapies with precise measurements of the scope of their action on diseased cells;
- prescription of a "personalized treatment" crafted to match the tumors identified;
- screening of high-risk patients previously detected by genetic profiling.
The benefits for patients are obvious: improved disease management and personalized treatment mean a more effective medical system.
Success is also crucial for public health: better diagnosis coupled with the prescription of drugs more precisely aimed at the target.